Hydrocodone Bitartrate And Acetaminophen Tablet
Product Images NDC 63629-2295

3 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrocodone Bitartrate And Acetaminophen (NDC 63629-2295). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure-1 (Hydrocodone Bitartrate And Acetaminophen Tablets 1)

Structure-1 (Hydrocodone Bitartrate And Acetaminophen Tablets 1)
Chemical structure diagram showing the molecular structures of hydrocodone bitartrate and acetaminophen.*
FDA Label Image

Structure-2 (Hydrocodone Bitartrate And Acetaminophen Tablets 2)

Structure-2 (Hydrocodone Bitartrate And Acetaminophen Tablets 2)
Chemical structure diagram showing the molecular structure of Hydrocodone Bitartrate and Acetaminophen. The diagram includes atoms and bonds representing the compound's chemical components.*
FDA Label Image

Label (Lbl636292295)

Label (Lbl636292295)
Packaging label for Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 7.5 mg/325 mg strength. The oral tablet product is labeled for prescription use only and comes in a 100-tablet count. The label includes storage instructions, caution about overdose and addiction risk, manufacturer Tirs Pharma, Inc., and relabeler Bryant Ranch Prepack.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.